Matthew Perrone | Manufacturing.net

Government officials speaking at a White House press conference

Lawmaker Raises Concerns over FDA's Ultra-Fast Drug Review Program

Drugmakers are promised expedited reviews for new medicines that support “national interests.”

February 4, 2026

The U.S. Food and Drug Administration campus in Silver Spring, Md., is photographed on Oct. 14, 2015.

Trump Administration Cuts Reach the FDA

The cuts have impacted employees in the agency's centers for food, medical devices and tobacco products.

February 17, 2025

A U.S. Food and Drug Administration building is seen behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md., on Aug. 2, 2018.

5 Takeaways From AP's Report on Big Backlog of Uninspected Drug Factories

Factories that haven't been inspected in five or more years are considered a significant risk.

September 6, 2024

Fda

Nearly 2,000 Drug Manufacturing Plants Are Overdue for FDA Inspections After COVID Delays

About 42% of the plants registered to produce drugs are overdue for safety and quality inspections.

September 5, 2024

The Altria Group Inc. corporate headquarters in Richmond, Va., is shown April 23, 2008.

Altria Makes $2.75B Investment in e-Cigarette Startup NJOY

The announcement comes days after the company said it was swapping its minority stake in Juul Labs.

March 6, 2023

Jeffrey Reed, who experienced persistent sinus infections and two bouts of pneumonia while using a Philips CPAP machine, poses with the device at his home Thursday, Oct. 20, 2022, in Marysville, Ohio.

Sleep Apnea Device Recall Drags On, Stoking Anger From Users

It has left patients to choose between using a potentially harmful device or trying risky remedies.

October 25, 2022

Shoppers shop at a grocery store in Glenview, Ill., Monday, July 4, 2022. Consumers spent a bit more in August than the previous month, a sign the economy is holding up even as inflation lifts prices for food, rent, and other essentials. Americans boosted their spending at stores and for services such as haircuts by 0.4% in August, after it fell 0.2% in July, the Commerce Department said Friday Sept. 30.

Resilient U.S. Consumers Spend Slightly More in August

Still, there were signs that rising prices are weighing on shoppers.

October 3, 2022

A 10-page report from the agency offers the first formal account of the factors that led to the ongoing infant formula shortage.

FDA Concedes Delays in Response to Baby Formula Shortage

A report offers the agency's first formal account of the factors that led to the ongoing shortage.

September 21, 2022

In a deal announced Tuesday, Sept. 6, 2022, electronic cigarette maker Juul Labs will pay nearly $440 million to settle a two-year investigation by 33 states into the marketing of its high-nicotine vaping products, which have long been blamed for sparking a national surge in teen vaping.

Juul to Pay Nearly $440M to Settle States' Teen Vaping Probe

Additionally, Juul faces hundreds of personal lawsuits.

September 7, 2022

This Thursday, Dec. 20, 2018 file photo shows a Juul electronic cigarette starter kit at a smoke shop in New York. Altria reports its nearly $13 billion investment in troubled vaping company Juul is worth 95% less than it originally paid. The tobacco giant on Thursday, July 28, 2022, said its stake in the e-cigarette maker is now worth less than $500 million after U.S. regulators announced plans to ban Juul's vaping devices.

Altria's $13B Juul Investment Vaporizes

It's now worth less than 5% of its original value.

July 28, 2022

FDA Commissioner Robert Califf said Tuesday, July 19, 2022, that he has commissioned an independent review of the FDA's food and tobacco programs following months of criticism over its handling of the baby formula shortage and e-cigarette reviews.

FDA Weighs Oversight Changes After Formula, Juul Troubles

Many controversies have plagued Commissioner Robert Califf's second stint running the agency.

July 20, 2022

Baby formula is displayed on the shelves of a grocery store in Carmel, Ind. on May 10, 2022. A bill introduced early June, 2022, would require the Food and Drug Administration to inspect infant formula facilities every six months. U.S. regulators have historically inspected baby formula plants at least once a year, but they did not inspect any of the three biggest manufacturers in 2020.

COVID Caused Gap in Baby Formula Plant Inspections

U.S. regulators did not inspect any of the three biggest manufacturers in 2020.

June 13, 2022

The 132 pallets of Nestlé Health Science Alfamino Infant and Alfamino Junior formula arrived from Ramstein Air Base in Germany.

Abbott Restarts Baby Formula Plant Linked to Contamination

The shutdown of the nation's largest formula factory led to supply problems expected to persist into the summer.

June 6, 2022

As the baby formula shortage continues in the United States, some parents are opting to cross the border into Mexico, where the shelves are still stocked with options to feed their babies.

FDA Chief to Detail Delays Inspecting Baby Formula Plant

An inspection began a month later than planned.

May 25, 2022

In this Dec. 11, 2006 file photo, a silicone gel breast implant is shown at Mentor Corp., a subsidiary of Johnson & Johnson, in Irving, Texas. On Wednesday, Oct. 27, 2021, U.S. health regulators finalized stronger warnings for breast implants, including a new requirement that people receive detailed information about their potential risks and complications before getting them.

FDA Sets Stronger Safety Warnings for Breast Implants

The new regulations are mainly aimed at implant manufacturers, who are also being required to add a boxed warning message.

October 28, 2021